Skip Navigation

Coronavirus (COVID-19) information for Dana-Farber patients & families Learn more

  • Dana-Farber Cancer Institute, a principal teaching affiliate of Harvard Medical School, shares advances in cancer research and treatment with the healthcare community through continuing medical education (CME) courses.

    Dana-Farber CME courses, offered in conjunction with Harvard Medical School or Partners HealthCare Office of Continuing Professional Development, which are both accredited by the Accreditation Council for Continuing Medical Education (ACCME), provide continuing medical education for physicians. These educational activities have been designated as credit towards the AMA Physician's Recognition Award.

    Upcoming Courses

    VIRTUAL CME: Lymphoma and Chronic Lymphocytic Leukemia: Updates in Management
    Saturday, April 2, 2022
    8:00 a.m.-1:40 p.m. ET
    Course and Registration Information

    Cancer Survivorship: Optimizing Care and Outcomes
    Online; self-paced
    Available until April 26, 2024
    Course and Registration Information

    Master Class for Oncologists Series
    Live, In-person course and Livestream
    October 21-22, 2022
    Chicago, IL

    Virtual Tumor Board Session – Hematologic Malignancies
    November 10, 2022

    Virtual Tumor Board Session – Women’s Cancers
    November 12, 2022

    Registration and series information

    Grand Rounds

    Dana-Farber is a teaching affiliate of Harvard Medical School and founder of Dana-Farber/Harvard Cancer Center, a Comprehensive Cancer Center designated by the National Cancer Institute.

    Visit our calendar of on-site educational opportunities for healthcare professionals, researchers and scientists, available through Dana-Farber and partnering institutions.